Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106503222 | 10650322 | 2 | F | 20140401 | 20160921 | 20141213 | 20160927 | EXP | IT-MINISAL02-281714 | IT-MYLANLABS-2014M1012845 | MYLAN | 0.00 | Y | 0.00000 | 20160927 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106503222 | 10650322 | 1 | PS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Oral | 100 MG, QD | Y | 200463 | 100 | MG | QD | ||||||
106503222 | 10650322 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG, QD | 11880 | MG | Y | 0 | 220 | MG | CAPSULE, HARD | QD | |||
106503222 | 10650322 | 3 | C | LASIX | FUROSEMIDE | 1 | Oral | 50 MG, UNK | D | 0 | 50 | MG | TABLET | ||||||
106503222 | 10650322 | 4 | C | KANRENOL | CANRENOATE POTASSIUM | 1 | Oral | 25 MG, UNK | D | 0 | 25 | MG | TABLET | ||||||
106503222 | 10650322 | 5 | C | PANTORC | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | D | 0 | 40 | MG | GASTRO-RESISTANT TABLET | ||||||
106503222 | 10650322 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, UNK | D | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
106503222 | 10650322 | 1 | Onychomycosis |
106503222 | 10650322 | 2 | Atrial fibrillation |
106503222 | 10650322 | 3 | Product used for unknown indication |
106503222 | 10650322 | 4 | Product used for unknown indication |
106503222 | 10650322 | 5 | Product used for unknown indication |
106503222 | 10650322 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
106503222 | 10650322 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
106503222 | 10650322 | Muscle haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
106503222 | 10650322 | 1 | 20140401 | 20140506 | 0 | |
106503222 | 10650322 | 2 | 20140207 | 20140727 | 0 |